Evaluating differences in whole blood, serum, and urine screening tests for zika virus, Puerto Rico, USA, 2016

  • Asher Y. Rosinger
  • , Samantha M. Olson
  • , Sascha R. Ellington
  • , Janice Perez-Padilla
  • , Regina M. Simeone
  • , Caitlin S. Pedati
  • , Betsy A. Schroeder
  • , Gilberto A. Santiago
  • , Freddy A. Medina
  • , Jorge L. Muñoz-Jordán
  • , Laura E. Adams
  • , Romeo R. Galang
  • , Miguel Valencia-Prado
  • , Sonia Bakkour
  • , Candimar Colón
  • , Mary Goodwin
  • , Dana Meaney-Delman
  • , Jennifer S. Read
  • , Lyle R. Petersen
  • , Denise J. Jamieson
  • Carmen C. Deseda, Margaret A. Honein, Brenda Rivera-García, Carrie K. Shapiro-Mendoza

Research output: Contribution to journalReview articlepeer-review

Abstract

We evaluated nucleic acid amplifi cation testing (NAAT) for Zika virus on whole-blood specimens compared with NAAT on serum and urine specimens among asymptomatic pregnant women during the 2015-2016 Puerto Rico Zika outbreak. Using NAAT, more infections were detected in serum and urine than in whole blood specimens.

Original languageEnglish (US)
Pages (from-to)1505-1508
Number of pages4
JournalEmerging infectious diseases
Volume27
Issue number5
DOIs
StatePublished - May 2021

All Science Journal Classification (ASJC) codes

  • Epidemiology
  • Microbiology (medical)
  • Infectious Diseases

Fingerprint

Dive into the research topics of 'Evaluating differences in whole blood, serum, and urine screening tests for zika virus, Puerto Rico, USA, 2016'. Together they form a unique fingerprint.

Cite this